Abolition and harm reduction in the struggle for "Care, Not Cages".

Abolitionist harm reduction Drug overdose and drug related harms Movement for harm reduction Movement for prison abolition Public health policy

Journal

The International journal on drug policy
ISSN: 1873-4758
Titre abrégé: Int J Drug Policy
Pays: Netherlands
ID NLM: 9014759

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 01 04 2023
revised: 11 08 2023
accepted: 13 08 2023
medline: 27 11 2023
pubmed: 19 9 2023
entrez: 18 9 2023
Statut: ppublish

Résumé

Care that is organized around the principles of harm reduction and the movement for police and prison abolition has the potential to uproot and transform structural causes of harm and violence, in the interconnected crises of drug-related harm, policing, and punishment. The United States' crisis of overdose and drug-related harm and its system of policing and punishment are historically and empirically linked phenomena. The abandonment of people whose use of drugs leads to their premature death, in the form of an overdose, is directly and indirectly connected to wider systems of criminalization and incarceration that also produce premature suffering and death. Organizations advocating for harm reduction for people who use drugs (PWUD) and organizations seeking the abolition of police and prisons have developed in parallel albeit with different genealogies. We examine the historical origins, principles, and practical applications of the two movements to identify points of overlap and lessons to be learned for the public health goals of addressing and preventing premature suffering and death in the United States. A case study of Los Angeles (LA) County, where elected officials have promised a new paradigm of care, not punishment, frames our analysis. We show how the principles and strategies of harm reduction and abolition are both necessary to practically realizing a paradigm of care, not punishment, and achieving system transformation.

Identifiants

pubmed: 37722347
pii: S0955-3959(23)00210-4
doi: 10.1016/j.drugpo.2023.104163
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104163

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jeremy Levenson (J)

Department of Psychiatry, Yale University, United States; Department of Anthropology, UCLA, United States; Center for Social Medicine, University of California Los Angeles, United States.

Lauren Textor (L)

Department of Anthropology, UCLA, United States; Center for Social Medicine, University of California Los Angeles, United States; Department of Psychiatry, UCLA, United States. Electronic address: LTextor@mednet.ucla.edu.

Ricky Bluthenthal (R)

Department of Preventive Medicine, Keck School of Medicine, USC, United States.

Anna Darby (A)

Emergency Medicine Program, LAC+USC Medical Center, Keck School of Medicine at USC, United States.

Rafik Wahbi (R)

Department of Community Health Sciences, UCLA Fielding School of Public Health, United States; Frontline Wellness Network, Los Angeles, United States.

Mark-Anthony Clayton-Johnson (MA)

Frontline Wellness Network, Los Angeles, United States; Dignity and Power Now, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH